What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0002056807
Total reported value
—
$240.9M
148 檔
15.4%
The Q4 2024 SEC filing reveals that Tema Etfs LLC held a total portfolio value of $240.9M, covering 148 public equity positions.
During Q4 2024, Tema Etfs LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
In terms of portfolio concentration, the top 5 core holdings (including ROK, AIT, PRIM) accounted for 15.4% of total reported equity market value during Q4 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ROK | Rockwell Automation Inc | Stock-Industrials | 3.79% | — | — | |
| 2 | AIT | Applied Industrial Tech Inc | Stock-Industrials | 3.37% | — | — | |
| 3 | PRIM | Primoris Services CORP | Stock-Industrials | 2.96% | — | — | |
| 4 | CLH | Clean Harbors Inc | Stock-Industrials | 2.74% | — | — | |
| 5 | TKR | Timken Co | Stock-Industrials | 2.58% | — | — | |
| 6 | IR | Ingersoll-rand Inc | Stock-Industrials | 2.56% | — | — | |
| 7 | VMC | Vulcan Materials Co | Stock-Materials | 2.53% | — | — | |
| 8 | FAST | Fastenal Co | Stock-Industrials | 2.49% | — | — | |
| 9 | SPXC | Spx Technologies Inc | Stock-Industrials | 2.46% | — | — | |
| 10 | LLY | Eli Lilly & Co | Stock-Healthcare | 2.29% | — | — | |
| 11 | PH | Parker Hannifin CORP | Stock-Industrials | 2.28% | — | — | |
| 12 | FLR | Fluor CORP | Stock-Industrials | 2.21% | — | — | |
| 13 | FSS | Federal Signal CORP | Stock-Industrials | 2.12% | — | — | |
| 14 | CAT | Caterpillar Inc | Stock-Industrials | 2.01% | — | — | |
| 15 | APG | Api Group CORP | Stock-Industrials | 1.93% | — | — | |
| 16 | EMR | Emerson Electric Co | Stock-Industrials | 1.90% | — | — | |
| 17 | ATMU | Atmus Filtration Technologie | Stock-Consumer Disc | 1.84% | — | — | |
| 18 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 1.84% | — | — | |
| 19 | WCC | Wesco International Inc | Stock-Industrials | 1.83% | — | — | |
| 20 | ATI | Ati Inc | Stock-Industrials | 1.77% | — | — | |
| 21 | HRI | Herc Holdings Inc | Stock-Other | 1.76% | — | — | |
| 22 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 1.73% | — | — | |
| 23 | BBIO | Bridgebio Pharma Inc | Stock-Healthcare | 1.62% | — | — | |
| 24 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 1.59% | — | — | |
| 25 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 1.29% | — | — | |
| 26 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 1.23% | — | — | |
| 27 | AMGN | Amgen Inc | Stock-Healthcare | 1.21% | — | — | |
| 28 | GILD | Gilead Sciences Inc | Stock-Healthcare | 1.18% | — | — | |
| 29 | TEX | Terex CORP | Stock-Industrials | 1.18% | — | — | |
| 30 | ARGX | Argenx Se - Adr | Stock-Healthcare | 1.17% | — | — | |
| 31 | ASND | Ascendis Pharma A/S | Stock-Other | 1.09% | — | — | |
| 32 | TSM | Taiwan Semiconductor-sp Adr | Stock-Tech | 0.93% | — | — | |
| 33 | CYTK | Cytokinetics Inc | Stock-Healthcare | 0.93% | — | — | |
| 34 | DXCM | Dexcom Inc | Stock-Healthcare | 0.92% | — | — | |
| 35 | INCY | Incyte CORP | Stock-Healthcare | 0.87% | — | — | |
| 36 | RVMD | Revolution Medicines Inc | Stock-Healthcare | 0.83% | — | — | |
| 37 | IONS | Ionis Pharmaceuticals Inc | Stock-Healthcare | 0.83% | — | — | |
| 38 | 2655787D | Blueprint Medicines CORP | Stock-Other | 0.81% | — | — | |
| 39 | ILMN | Illumina Inc | Stock-Healthcare | 0.79% | — | — | |
| 40 | BSX | Boston Scientific CORP | Stock-Healthcare | 0.76% | — | — | |
| 41 | MIRM | Mirum Pharmaceuticals Inc | Stock-Other | 0.72% | — | — | |
| 42 | NTLA | Intellia Therapeutics Inc | Stock-Other | 0.72% | — | — | |
| 43 | UNP | Union Pacific CORP | Stock-Industrials | 0.70% | — | — | |
| 44 | EXEL | Exelixis Inc | Stock-Healthcare | 0.68% | — | — | |
| 45 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 0.66% | — | — | |
| 46 | MASI* | Masimo CORP | Stock-Other | 0.66% | — | — | |
| 47 | DHR | Danaher CORP | Stock-Healthcare | 0.65% | — | — | |
| 48 | PODD | Insulet CORP | Stock-Healthcare | 0.58% | — | — | |
| 49 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 0.55% | — | — | |
| 50 | MCO | Moody's CORP | Stock-Financials | 0.51% | — | — |
According to official SEC Form 13F filings, Tema Etfs LLC reported a total U.S. public equity portfolio value of $240.9M across 148 disclosed positions in Q4 2024.
During Q4 2024, Tema Etfs LLC's top holdings by market value included ROK (3.8%)、AIT (3.4%)、PRIM (3.0%). The largest single position, ROK, represented 3.8% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In Q4 2024, Tema Etfs LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.